Citations for
1MAGEA3
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J.
Cancers (Basel) May 15;11(5):677. doi: 10.3390/cancers11050677 2019
2MAGEA3, MAGEB4, ODF4
Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
Afsharpad M, Nowroozi MR, Mobasheri MB, Ayati M, Nekoohesh L, Saffari M, Zendehdel K, Modarressi MH.
Pathol Oncol Res. Jan;25(1):191-199. doi: 10.1007/s12253-017-0313-4. Epub 2017 Oct 20 2019
3GPC3, MAGEA1, MAGEA3
MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.
Gu L, Sang M, Yin D, Liu F, Wu Y, Liu S, Huang W, Shan B.
Thorac Cancer 9(4):431-438. doi: 10.1111/1759-7714.12571. Epub 2018 Feb 12. 2018
4MAGEA3
Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.
Chen X, Wang L, Liu J, Huang L, Yang L, Gao Q, Shi X, Li J, Li F, Zhang Z, Zhao S, Zhang B, Van der Bruggen P, Zhang Y.
Oncol Lett. Mar;13(3):1609-1618. doi: 10.3892/ol.2017.5665. Epub 2017 Feb 1 2017
5MAGEA2, MAGEA3, MAGEB2, MAGEC2, NXF2
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.
Van Tongelen A, Loriot A, De Smet C.
Cancer Lett. Jun 28;396:130-137. doi: 10.1016/j.canlet.2017.03.029. Epub 2017 Mar 22 2017
6MAGEA1, MAGEA2, MAGEA3, MAGEA5, MAGEA8
The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice.
Hou S, Xian L, Shi P, Li C, Lin Z, Gao X.
Sci Rep. May 26;6:26735. doi: 10.1038/srep26735 2016
7MAGEA3
MAGE-A3: an immunogenic target used in clinical practice.
Esfandiary A, Ghafouri-Fard S.
Immunotherapy 7(6):683-704. doi: 10.2217/imt.15.29. Epub 2015 Jun 23 2015
8MAGEA3
MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
Yin B, Zeng Y, Liu G, Wang X, Wang P, Song Y.
Int J Clin Exp Pathol. May 15;7(6):2934-41. eCollection 2014 2014
9MAGEA3
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.
Dyrskjøt L, Zieger K, Kissow Lildal T, Reinert T, Gruselle O, Coche T, Borre M, Ørntoft TF.
Br J Cancer Jun 26;107(1):116-22. doi: 10.1038/bjc.2012.215. Epub 2012 May 17 2012
10CTCFL, MAGEA2, MAGEA3, MAGEA4
BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.
Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA.
Clin Cancer Res. Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10 2011
11MAGEA3, MAGEA4, MAGEA6, MAGEA8
Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks.
Lifantseva N, Koltsova A, Krylova T, Yakovleva T, Poljanskaya G, Gordeeva O.
Stem Cells Int. 2011:795239. doi: 10.4061/2011/795239. Epub 2011 Jul 18 2011
12MAGEA1, MAGEA10, MAGEA12, MAGEA2, MAGEA3, MAGEA4
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
Andrade VC, Vettore AL, Felix RS, Almeida MS, Carvalho F, Oliveira JS, Chauffaille ML, Andriolo A, Caballero OL, Zago MA, Colleoni GW.
Cancer Immun 8:2. 2008
13CTAG1B, MAGEA3, MAGEA4
Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J, Samija M, Juretić A, Sarcević B, Sobat H.
Coll Antropol 32(3):731-6.PMID: 18982744 2008
14MAGEA3
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
Liu W, Cheng S, Asa SL, Ezzat S.
Cancer Res 68(19):8104-12.PMID: 18829569 2008
15FGFR2, MAGEA3
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
Zhu X, Asa SL, Ezzat S.
Clin Cancer Res 14(7):1984-96.PMID: 18381936 2008
16CTAG1, MAGEA1, MAGEA3, MAGEA4, MAGEA6, MAGEC1, MAGEC2, SLCO6A1, SYCP1, TPTE
Cancer-testis (CT) antigen expression in medulloblastoma.
Oba-Shinjo SM, Caballero OL, Jungbluth AA, Rosemberg S, Old LJ, Simpson AJ, Marie SK.
Cancer Immun 8:7. 2008
17MAGEA3
Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
J Invest Dermatol 127(9):2123-8. Epub 2007 May 10. 2007
18MAGEA1, MAGEA12, MAGEA2, MAGEA3, MBD1, MBD2, MECP2
Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F, Friese O, Pantel K, Schwarzenbach H.
Mol Cancer Res 5(7):749-59. 2007
19MAGEA1, MAGEA3
Epigenetic control of MAGE gene expression by the KIT tyrosine kinase.
Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ.
J Invest Dermatol 127(9):2123-8. Epub 2007 May 10.PMID: 17495964 2007
20MAGEA1, MAGEA3
5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
Qiu G, Fang J, He Y.
Clin Biochem 39(3):259-66. Epub 2006 Mar 6. 2006
21MAGEA1, MAGEA3
Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH, Choi JS, Kim IJ, Ku JL, Park JG.
World J Gastroenterol 12(35):5651-7.PMID: 17007017 2006
22MAGEA1, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA6
MAGE-A gene expression pattern in primary breast cancer.
Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Loning T, Janicke F, Pantel K.
Cancer Res 61(18):6682-7. 2001
23MAGEA1, MAGEA3, PRAME
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
Pellat-Deceunynck C, Mellerin MP, Labarriere N, Jego G, Moreau-Aubry A, Harousseau JL, Jotereau F, Bataille R.
Eur J Immunol 30(3):803-9. 2000
24MAGEA1, MAGEA3
Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
Kariyama K, Higashi T, Kobayashi Y, Nouso K, Nakatsukasa H, Yamano T, Ishizaki M, Kaneyoshi T, Toshikuni N, Ohnishi T, Fujiwara K, Nakayama E, Terracciano L, Spagnoli GC, Tsuji T.
Br J Cancer 81(6):1080-7 1999
25MAGEA3
Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck.
Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC, Yu TH.
Anticancer Res 19(6B):5037-42. 1999
26MAGEA1, MAGEA10, MAGEA2, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
Serrano A, Lethé B, Delroisse JM, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T.
Int J Cancer 83(5):664-9. 1999
27MAGEA1, MAGEA2B, MAGEA3
Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2.
Ofuji S, et al.
Anticancer Res 18 : 3639-3644. 1998
28MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28.
Rogner UC, Wilke K, Steck E, Korn B, Poustka A.
Genomics 29(3):725-31. 1995
29MAGEA@, MAGEA1, MAGEA2B, MAGEA3
Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter : implications for MAGE immunotherapy.
Oaks MK, et al.
Cancer Res 54 : 1627-1629. 1994
30MAGEA1, MAGEA10, MAGEA11, MAGEA12, MAGEA2, MAGEA2B, MAGEA3, MAGEA4, MAGEA5, MAGEA6, MAGEA7, MAGEA8, MAGEA9, MAGEA9B, MAGEA@
Structure, chromosomal localization, and expression of 12 genes of the MAGE family.
De Plaen E, et al.
Immunogenetics 40 : 360-369. 1994
31MAGEA1, MAGEA3, MAGEA12
Cloning and analysis of MAGE-1-related genes.
Ding M, et al.
Biochem Biophys Res Commun 202 : 549-555. 1994